You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 17, November 5, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Breast Cancer
 •Statistics and Research Methods
 •Women's Health
 •Women's Health, Other
 •Hematology/ Hematologic Malignancies
 •Leukemias/ Lymphomas
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Challenges of Epidemiologic Research in Non-Hodgkin Lymphoma

Andrew M. Evens, DO, MS; Brian C.-H. Chiu, PhD

JAMA. 2008;300(17):2059-2061.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The incidence of non-Hodgkin lymphoma (NHL) increased by more than 80% between 1975 and 1991 in the United States, representing one of the largest increases of any cancer.1 While the overall NHL incidence rates began to stabilize in the late 1990s, the temporal trends varied by histologic subtype with the incidence of T/NK [natural killer]–cell lymphomas increasing 4% per year during 1992-2001 compared with 0.5% per year for B-cell lymphoma.2 Part of the overall steep increase in NHL incidence over the last several decades is due to human immunodeficiency virus (HIV) infection, although the incidence of NHL has been increasing irrespective of HIV status.3 Other pathogenic associations with NHL include viruses and bacteria (eg, human T-cell lymphotropic virus type 1,4 human herpesvirus 8,5 hepatitis C,6 and Helicobacter pylori7) and medications that cause extreme immunodeficiency. However, the etiology of NHL remains . . . [Full Text of this Article]

Author Affiliations: Division of Hematology/Oncology, Department of Medicine (Dr Evens), The Robert H. Lurie Comprehensive Cancer Center (Drs Evens and Chiu), and Department of Preventive Medicine (Dr Chiu), Northwestern University Feinberg School of Medicine, Chicago, Illinois.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Anaplastic Large-Cell Lymphoma in Women With Breast Implants
Daphne de Jong, Wies L. E. Vasmel, Jan Paul de Boer, Gideon Verhave, Ellis Barbé, Mariel K. Casparie, and Flora E. van Leeuwen
JAMA. 2008;300(17):2030-2035.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.